Nội tiết | Medical News

Voice-based AI makes insulin management a breeze for T2D patients

Jairia Dela Cruz, 20240113140000

A voice-based conversational artificial intelligence application helps type 2 diabetes (T2D) patients navigate basal insulin titration at home and, in turn, achieve rapid glycaemic control, as reported in a study.

Semaglutide trims down weight in patients with severe obesity

Stephen Padilla, 20240112120000

Use of semaglutide 2.4 mg results in substantial weight reduction in patients with severe obesity who had previously undergone bariatric surgery (BS) but failed to achieve satisfactory weight loss, reports a recent study.

NIH study: Semaglutide associated with lower risk of suicidal ideation

Kanas Chan, 20240111000000

Semaglutide is associated with a 49─73 percent lower risk of suicidal ideation vs other agents for treatment of obesity and type 2 diabetes mellitus (T2DM), a National Institutes of Health (NIH)─funded study has shown.

Aspirin reduces liver fat, improves markers of inflammation, fibrosis

Elvira Manzano, 20240104000000

Patients with metabolic dysfunction-associated steatotic liver disease (MASLD) – previously called nonalcoholic fatty liver disease (NAFLD) – but without cirrhosis, who were treated with daily low-dose aspirin, had significant reductions in liver fat for 6 months in a new trial.

Shifting to a plant-based diet may be key to better cardiometabolic health

Audrey Abella, 20231227100000

A systematic review and meta-analysis of prospective studies demonstrate that switching from animal-based (AB) to plant-based (PB) foods conferred cardiometabolic improvements.

Somapacitan safe, effective in children with growth hormone deficiency

Stephen Padilla, 20231221120000

Use of somapacitan, a long-acting growth hormone (GH) derivative, for 2 years is efficacious and well tolerated in prepubertal children with GH deficiency (GHD), reports a study.

Real-world data favour etelcalcetide for treating SHPT in multiethnic Asians

Jairia Dela Cruz, 20231218140000

Etelcalcetide proves beneficial in the real-world treatment of secondary hyperparathyroidism (SHPT) in multiethnic Asian haemodialysis patients, with the added advantage of reducing pill burden, as shown in a study from Singapore.

Weight loss with tirzepatide reversed after stopping treatment

Jairia Dela Cruz, 20231216140000

For individuals with overweight or obesity who are taking tirzepatide for weight management, continued treatment results in sustained and even augmented weight loss. When treatment is stopped, however, the achieved weight loss is substantially reversed.

Teplizumab preserves ß-cell function in children with new-onset T1D

Elaine Soliven, 20231215000000

Treatment with teplizumab significantly preserved beta(ß)-cell function, as measured by C-peptide levels, in children and adolescents with new-onset type 1 diabetes (T1D) compared with placebo, according to the PROTECT* study.

Vegan better than omnivorous diet for heart and metabolism

Jairia Dela Cruz, 20231212140000

Vegan diet confers cardiometabolic advantages compared with healthy omnivorous diet, as shown in a twins study.